Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

800
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
800
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

461
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

879
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
879
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Novel 17β-HSD10 Inhibitors and Their Evaluation in an <i>In Vitro</i> Model of Alzheimer's Disease.

ACS medicinal chemistry letters·2026
Same author

Host soluble plasma factors increase dual-species Staphylococcus epidermidis and Candida albicans biofilm biomass without enhancing stress tolerance.

Scientific reports·2026
Same author

Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoning.

Archives of toxicology·2026
Same author

4-[(Aryloylhydrazineylidene)methyl]-N-phenylbenzamides as a new class of antimycobacterial agents: design, synthesis and biological evaluation.

Bioorganic chemistry·2026
Same author

Activity Profiling of Nitro-Substituted Di(Hetero)Aryl 1,3,4- and 1,2,4-Oxadiazoles: Antimicrobial, Cholinesterase Inhibition and Antioxidant Potential.

Archiv der Pharmazie·2026
Same author

Novel pyrimidine derivatives as promising antimycobacterial agents.

European journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jan 6, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K

Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies.

Ondrej Kovar1,2, Martin Kufa1,2, Vladimir Finger1,2

  • 1Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, Hradec Kralove 500 03, Czech Republic.

Journal of Medicinal Chemistry
|October 7, 2025
PubMed
Summary

Scaffold hopping is a medicinal chemistry strategy that modifies drug structures to combat drug-resistant tuberculosis (TB). This approach accelerates the discovery of new TB therapeutics with improved efficacy and safety profiles.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.3K

Related Experiment Videos

Last Updated: Jan 6, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.3K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Tuberculosis Therapeutics

Background:

  • Tuberculosis (TB) remains a significant global health threat, exacerbated by drug-resistant Mycobacterium tuberculosis (Mtb) strains.
  • Existing anti-TB drugs face limitations, including toxicity and the emergence of resistance.

Purpose of the Study:

  • To explore the application of scaffold hopping in developing novel anti-TB therapeutics.
  • To highlight scaffold hopping's role in overcoming limitations of current TB drugs.

Main Methods:

  • Review of scaffold hopping strategies applied to Mycobacterium tuberculosis (Mtb) drug discovery.
  • Analysis of case studies involving structural modifications targeting key Mtb pathways.
  • Consideration of both traditional and in silico approaches to scaffold hopping.

Main Results:

  • Scaffold hopping has successfully identified novel compounds targeting essential Mtb pathways like energy metabolism and cell wall synthesis.
  • This approach has led to compounds with enhanced pharmacokinetic properties, efficacy, and reduced toxicity.
  • Scaffold hopping facilitates the circumvention of existing drug resistance mechanisms.

Conclusions:

  • Scaffold hopping is a versatile and innovative medicinal chemistry strategy for accelerating TB drug discovery.
  • It offers a promising avenue to develop next-generation anti-TB drugs capable of addressing resistance and improving treatment outcomes.